Literature DB >> 29728293

Premature mortality among people with severe mental illness - New evidence from linked primary care data.

Ann John1, Joanna McGregor2, Ian Jones3, Sze Chim Lee2, James T R Walters3, Michael J Owen3, Michael O'Donovan3, Marcos DelPozo-Banos2, Damon Berridge4, Keith Lloyd2.   

Abstract

Studies assessing premature mortality in people with severe mental illness (SMI) are usually based in one setting, hospital (secondary care inpatients and/or outpatients) or community (primary care). This may lead to ascertainment bias. This study aimed to estimate standardised mortality ratios (SMRs) for all-cause and cause-specific mortality in people with SMI drawn from linked primary and secondary care populations compared to the general population. SMRs were calculated using the indirect method for a United Kingdom population of almost four million between 2004 and 2013. The all-cause SMR was higher in the cohort identified from secondary care hospital admissions (SMR: 2.9; 95% CI: 2.8-3.0) than from primary care (SMR: 2.2; 95% CI: 2.1-2.3) when compared to the general population. The SMR for the combined cohort was 2.6 (95% CI: 2.5-2.6). Cause specific SMRs in the combined cohort were particularly elevated in those with SMI relative to the general population for ill-defined and unknown causes, suicide, substance abuse, Parkinson's disease, accidents, dementia, infections and respiratory disorders (particularly pneumonia), and Alzheimer's disease. Solely hospital admission based studies, which have dominated the literature hitherto, somewhat over-estimate premature mortality in those with SMI. People with SMI are more likely to die by ill-defined and unknown causes, suicide and other less common and often under-reported causes. Comprehensive characterisation of mortality is important to inform policy and practice and to discriminate settings to allow for proportionate interventions to address this health injustice.
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Mortality; Primary care; Schizophrenia; Severe mental illness

Mesh:

Year:  2018        PMID: 29728293     DOI: 10.1016/j.schres.2018.04.009

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  22 in total

Review 1.  Cardiovascular disease in patients with severe mental illness.

Authors:  René Ernst Nielsen; Jytte Banner; Svend Eggert Jensen
Journal:  Nat Rev Cardiol       Date:  2020-10-30       Impact factor: 32.419

2.  Excess Mortality and Life-Years Lost in People With Schizophrenia and Other Non-affective Psychoses: An 11-Year Population-Based Cohort Study.

Authors:  Nicholas Chak Lam Yung; Corine Sau Man Wong; Joe Kwun Nam Chan; Eric Yu Hai Chen; Wing Chung Chang
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 9.306

Review 3.  Evolving Models of Integrated Behavioral Health and Primary Care.

Authors:  Parashar Ramanuj; Erin Ferenchik; Mary Docherty; Brigitta Spaeth-Rublee; Harold Alan Pincus
Journal:  Curr Psychiatry Rep       Date:  2019-01-19       Impact factor: 5.285

4.  "Being There" vs "Being Direct:" Perspectives of Persons with Serious Mental Illness on Receiving Support with Physical Health from Peer and Non-Peer Providers.

Authors:  Lauren Bochicchio; Ana Stefancic; Charles McTavish; Daniela Tuda; Leopoldo J Cabassa
Journal:  Adm Policy Ment Health       Date:  2021-01-21

5.  Exploring high mortality rates among people with multiple and complex needs: a qualitative study using peer research methods.

Authors:  Rachel Perry; Emma A Adams; Jill Harland; Angela Broadbridge; Emma L Giles; Grant J McGeechan; Amy O'Donnell; Sheena E Ramsay
Journal:  BMJ Open       Date:  2021-06-03       Impact factor: 2.692

6.  Development of a peer-led, network mapping intervention to improve the health of individuals with severe mental illnesses: protocol for a pilot study.

Authors:  Jennifer Rose Deborah Collom; Jonathan Davidson; Daryl Sweet; Steve Gillard; Vanessa Pinfold; Claire Henderson
Journal:  BMJ Open       Date:  2019-06-29       Impact factor: 2.692

7.  Economic evaluation in psychiatric pharmacogenomics: a systematic review.

Authors:  Kariofyllis Karamperis; Maria Koromina; Panagiotis Papantoniou; Maria Skokou; Filippos Kanellakis; Konstantinos Mitropoulos; Athanassios Vozikis; Daniel J Müller; George P Patrinos; Christina Mitropoulou
Journal:  Pharmacogenomics J       Date:  2021-07-02       Impact factor: 3.550

8.  Mental illness attitudes and knowledge in non-specialist medical doctors working in state and private sectors.

Authors:  Yumna Minty; Mahomed Y H Moosa; Fatima Y Jeenah
Journal:  S Afr J Psychiatr       Date:  2021-05-31       Impact factor: 1.550

Review 9.  Why are somatic diseases in bipolar disorder insufficiently treated?

Authors:  René Ernst Nielsen; Pirathiv Kugathasan; Sune Straszek; Svend Eggert Jensen; Rasmus W Licht
Journal:  Int J Bipolar Disord       Date:  2019-05-05

10.  Management of clozapine treatment during the COVID-19 pandemic.

Authors:  Siobhan Gee; Fiona Gaughran; James MacCabe; Sukhi Shergill; Eromona Whiskey; David Taylor
Journal:  Ther Adv Psychopharmacol       Date:  2020-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.